Live Breaking News & Updates on Single Source Drugs

On June 30, 2023, the Centers for Medicare and Medicaid Services (CMS) released its much-anticipated final guidance ("Final Guidance") for the Medicare Drug Price Negotiation Program. ....

United States , Elena Klonoski , Lauren Limbach , Centers For Medicare , Manufacturer Discount Program , Negotiation Program , Office Of The Inspector , Medicare Drug Price Negotiation Program , Medicare Coverage Gap Discount Program , Medicaid Drug Rebate Program , Coverage Gap Discount Program , Public Health Service , Employer Group Waiver , Medicaid Services , Inflation Reduction , Final Guidance , Initial Guidance , Initial Price Applicability , Single Source Drugs , New Drug Applications , Biologics License , Orphan Drug Exclusion , Spend Medicare Drug Exclusion , Derived Products Exclusion , Plasma Derived Products Exclusion , Plasma Derived Products ,